On Monday — seven days after surgery — I was officially back at work and got my splint removed, too. When Dr. Kolker handed me the mirror for the big reveal, I almost didn't want to look. But when I did, I literally cried tears of joy. I truly hated my nose before, and suddenly it was so cute. It's tinier, and I love that the tip doesn't jut out the way it used to. I can't believe this is my new nose! It’s a wonderful relief to finally be proud of a feature that never felt right to me.
I felt particularly insecure about my nose when starting college, as I was presenting myself to the world, independently, for the first time. Whenever I met anyone new, I'd be very careful to talk to them only head-on, so they couldn't glimpse my profile. By 19, I was researching rhinoplasty surgery, and my dad even took me for a nose-job consultation, but I didn't feel the surgeon was a good fit, so we decided to table the idea.
I felt particularly insecure about my nose when starting college, as I was presenting myself to the world, independently, for the first time. Whenever I met anyone new, I'd be very careful to talk to them only head-on, so they couldn't glimpse my profile. By 19, I was researching rhinoplasty surgery, and my dad even took me for a nose-job consultation, but I didn't feel the surgeon was a good fit, so we decided to table the idea.
The FDA has identified that breast implants may be associated with a rare form of cancer called anaplastic large-cell lymphoma, believed to be associated with chronic bacterial inflammation.[69] Similar ALCL phenomena have been seen with other types of medical implants including vascular access ports, orthopedic hip implants, and jaw (TMJ) implants. As of February 1, 2017, the FDA has received a total of 359 medical device reports of breast-implant-associated ALCL (BIALCL), including 9 deaths.[70] Most cases of breast implant-associated ALCL had implants in for many years prior to the condition, and are usually treated successfully by simple removal of the implant and the capsule surrounding the implant without the need for chemotherapy if no evidence of systemic disease exists. If women with implants present with delayed swelling or fluid collection, cytologic studies and test for a marker "CD30" are suggested. The American Society of Plastic Surgery (ASPS) states, "CD30 is the main diagnostic test that must be performed on the seroma fluid as routine pathology or H&E staining can frequently miss the diagnosis." [71] Diagnosis and treatment of breast implant associated ALCL now follows standardized guidelines established by the National Comprehensive Cancer Network.[72]
×